BeStock  
Stocks › Biotechnology › SLN

Silence Therapeutics SLN

US equityMarket cap rank #3022Biotechnology
$19.81 +$0.00 (0.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $19.81 0.00%
Open$19.81
Prev close$19.81
Day range$19.80 – $19.83
Volume399.1K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

SLN at a glance

Silence Therapeutics stock (SLN) sits at $19.81, flat today. The business is worth $1.23B in the market, good for #3022 of 3753 on our coverage list.

Shares are at a 52-week high, after a year that ran from $4.19 to $19.87. Holders are ahead 213.9% over twelve months, and up 49.1% across the last three months.

On the chart it holds above both the 50-day ($15.28) and 200-day ($10.16) moving averages; RSI is 78, which some call overbought, and the last 30 sessions moved at roughly 240% annualized volatility.

In the quarter ended Sep 2026 the company brought in $0.00 of revenue, down 100.0% from a year earlier, and a net loss of $12.43M.

4 analysts follow the stock and the average call is "hold". The mean target, $20.00, sits 1.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$19.64 / $19.90
Average price today$19.81
Volume399.1KAvg (90d) 2.18M
Turnover$7.91M
Turnover rate0.80%of shares outstanding
Volume ratio0.49vs. recent average pace
Day amplitude0.15%
Market cap$1.23B
Float market cap$993.90M
Shares outstanding50.17M
EPS (TTM)-$1.89
P/B-5.73
Book value / share-$3.46
Net profit (TTM)-$117.56M
Net assets-$215.04M
30-day volatility239.6%annualized
Avg daily range (ATR)0.26%of price, 14 days
Max drawdown (1y)-43.7%-0.1% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

A
Momentum

Trading closer to its 52-week high than most peers scores higher.

C
Wall Street

4 analysts, consensus Hold.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 27.0 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability9.9
Momentum100.0
Financial health76.5
Analyst view1.2

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$20.00+1.0% vs. current price
Consensus ratingHold4 analysts covering
Morningstar fair value$23.98Price is below fair value

Wall Street’s average 12-month target is $20.00, 1.0% above today’s price, with a consensus rating of Hold. Morningstar’s fair value model puts the stock at $23.98, so shares trade 17.4% below that estimate. On earnings multiple, it sits in the 0th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+0.0%
1 week
-0.1%
1 month
+0.8%
3 months
+49.1%
6 months
+219.5%
Year to date
+225.8%
1 year
+213.9%
Day range
$19.80$19.83
52-week range
$4.19$19.87

Technical signals

Full technicals →
Trend readStrong uptrend

5 bullish · 1 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+0.2%Bullish
Price vs 50-day average+29.6%Bullish
Price vs 200-day average+95.1%Bullish
50-day vs 200-day50d above 200dBullish
RSI (14)77.6Neutral
MACD (12,26,9)1.20Bearish
Bollinger band position73%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How SLN ranks on BeStock

Market value#3010 of 3734
Closeness to 52-week high#23 of 3724
Dollar volume today#2516 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

SLN is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on SLN.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on SLN

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

SLN stock: common questions

What is SLN's latest share price?

$19.81 is the latest print for SLN, a move of +0.00% against yesterday's close of $19.81. Today's low and high so far: $19.80 and $19.83.

How big is Silence Therapeutics?

Equity value comes to $1.23B at the current price. By that measure it is number 3022 of the 3753 names in our coverage.

Where does SLN sit in its 52-week range?

The year's floor is $4.19 and the ceiling $19.87. Shares are 0.3% away from that ceiling.

Does SLN send cash back through a dividend?

Our data shows no dividend paid by Silence Therapeutics over the trailing twelve months.

Do Wall Street analysts like SLN?

Of 4 analysts, 0% say buy, 100% hold and 0% sell. Price targets average $20.00, with the most cautious at $20.00 and the most optimistic at $20.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on SLN.

Sign in to join the discussion.

Scroll to Top